UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 141

Sortiert nach

Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1-5 and Superoxide Dismutase 1-3 Signal Transduction Pathways

Antioxidants & redox signaling, 2019-01, Vol.30 (3), p.443

2019

Link zum Volltext

Verfügbarkeit prüfen

Extracellular Superoxide Dismutase: Growth Promoter or Tumor Suppressor?

Oxidative medicine and cellular longevity, 2016-01, Vol.2016, p.3612589-9

2016

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression

Stem cells international, 2016-01, Vol.2016, p.4824573-11

2016

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic regulation of miR-212 expression in lung cancer

PloS one, 2011-11, Vol.6 (11), p.e27722

2011

Link zum Volltext

Verfügbarkeit prüfen

Aminated Graphene Oxide as a Potential New Therapy for Colorectal Cancer

Oxidative medicine and cellular longevity, 2019-01, Vol.2019, p.3738980-15

2019

Link zum Volltext

Verfügbarkeit prüfen

SOD3 reduces inflammatory cell migration by regulating adhesion molecule and cytokine expression

PloS one, 2009-06, Vol.4 (6), p.e5786-e5786

2009

Link zum Volltext

Verfügbarkeit prüfen

A Timeless Link Between Circadian Patterns and Disease

Trends in molecular medicine, 2016-01, Vol.22 (1), p.68-81

2016

Link zum Volltext

Verfügbarkeit prüfen

Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1/2 Drivers in Thyroid Cancer Cells

Thyroid (New York, N.Y.), 2021-01, Vol.31 (1), p.76

2021

Link zum Volltext

Verfügbarkeit prüfen

Extracellular superoxide dismutase regulates the expression of small gtpase regulatory proteins GEFs, GAPs, and GDI

PloS one, 2015-03, Vol.10 (3), p.e0121441-e0121441

2015

Link zum Volltext

Verfügbarkeit prüfen

Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications

Current drug targets, 2016-04, Vol.17 (5), p.508

2016

Link zum Volltext

Verfügbarkeit prüfen

Convolutional Neural Networks in the Diagnosis of Colon Adenocarcinoma

AI (Basel), 2024-01, Vol.5 (1), p.324-341

2024

Link zum Volltext

Verfügbarkeit prüfen

TGF-beta1, WNT, and SHH signaling in tumor progression and in fibrotic diseases

Frontiers in bioscience (Scholar edition), 2017-01, Vol.9 (1), p.31

2017

Link zum Volltext

Verfügbarkeit prüfen

Hijacking the Hedgehog Pathway in Cancer Therapy

Anti-cancer agents in medicinal chemistry, 2016-03, Vol.16 (3), p.309

2016

Link zum Volltext

Verfügbarkeit prüfen

The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer

EBioMedicine, 2018-07, Vol.33, p.105-121

2018

Link zum Volltext

Verfügbarkeit prüfen

SOD3 Is a Non-Mutagenic Growth Regulator Affecting Cell Migration and Proliferation Signal Transduction

Antioxidants, 2021-04, Vol.10 (5), p.635

2021

Link zum Volltext

Verfügbarkeit prüfen

ERK2 Is a Promoter of Cancer Cell Growth and Migration in Colon Adenocarcinoma

Antioxidants, 2024-01, Vol.13 (1), p.119

2024

Link zum Volltext

Verfügbarkeit prüfen

Extracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and Migration

Scientific reports, 2017-02, Vol.7 (1), p.41416, Article 41416

2017

Link zum Volltext

Verfügbarkeit prüfen

Suppression of Gut Bacterial Translocation Ameliorates Vascular Calcification through Inhibiting Toll-Like Receptor 9-Mediated BMP-2 Expression

Oxidative medicine and cellular longevity, 2019-01, Vol.2019, p.3415682-12

2019

Link zum Volltext

Verfügbarkeit prüfen

The Interplay between Colon Cancer Cells and Tumour-Associated Stromal Cells Impacts the Biological Clock and Enhances Malignant Phenotypes

Cancers, 2019-07, Vol.11 (7), p.988

2019

Link zum Volltext

Verfügbarkeit prüfen

Redox-Activated Signal Transduction Pathways Mediating Cellular Functions in Inflammation, Differentiation, Degeneration, Transformation, and Death

Oxidative medicine and cellular longevity, 2016-01, Vol.2016, p.8479718-2

2016

Link zum Volltext

Verfügbarkeit prüfen

A dual mechanism of activation of the Sonic Hedgehog pathway in anaplastic thyroid cancer: crosstalk with RAS-BRAF-MEK pathway and ligand secretion by tumor stroma

Oncotarget, 2018-01, Vol.9 (4), p.4496-4510

2018

Link zum Volltext

Verfügbarkeit prüfen

SOD3 decreases ischemic injury derived apoptosis through phosphorylation of Erk1/2, Akt, and FoxO3a

PloS one, 2011-08, Vol.6 (8), p.e24456-e24456

2011

Link zum Volltext

Verfügbarkeit prüfen

Leukocyte trafficking is not affected by multikinase inhibitors sunitinib or sorafenib in mice

International journal of cancer, 2016-11, Vol.139 (10), p.2270-2276

2016

Link zum Volltext

Verfügbarkeit prüfen

Ras Oncogene-Mediated Progressive Silencing of Extracellular Superoxide Dismutase in Tumorigenesis

BioMed research international, 2015-01, Vol.2015, p.780409-13

2015

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation

Oncotarget, 2017-09, Vol.8 (40), p.67592-67604

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Englisch
(141)
Japanisch
(27)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1-5 and Superoxide Dismutase 1-3 Signal Transduction Pathways

Extracellular Superoxide Dismutase: Growth Promoter or Tumor Suppressor?

Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression

Epigenetic regulation of miR-212 expression in lung cancer

Aminated Graphene Oxide as a Potential New Therapy for Colorectal Cancer

SOD3 reduces inflammatory cell migration by regulating adhesion molecule and cytokine expression

A Timeless Link Between Circadian Patterns and Disease

Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1/2 Drivers in Thyroid Cancer Cells

Extracellular superoxide dismutase regulates the expression of small gtpase regulatory proteins GEFs, GAPs, and GDI

Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications

Convolutional Neural Networks in the Diagnosis of Colon Adenocarcinoma

TGF-beta1, WNT, and SHH signaling in tumor progression and in fibrotic diseases

Hijacking the Hedgehog Pathway in Cancer Therapy

The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer

SOD3 Is a Non-Mutagenic Growth Regulator Affecting Cell Migration and Proliferation Signal Transduction

ERK2 Is a Promoter of Cancer Cell Growth and Migration in Colon Adenocarcinoma

Extracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and Migration

Suppression of Gut Bacterial Translocation Ameliorates Vascular Calcification through Inhibiting Toll-Like Receptor 9-Mediated BMP-2 Expression

The Interplay between Colon Cancer Cells and Tumour-Associated Stromal Cells Impacts the Biological Clock and Enhances Malignant Phenotypes

Redox-Activated Signal Transduction Pathways Mediating Cellular Functions in Inflammation, Differentiation, Degeneration, Transformation, and Death

A dual mechanism of activation of the Sonic Hedgehog pathway in anaplastic thyroid cancer: crosstalk with RAS-BRAF-MEK pathway and ligand secretion by tumor stroma

SOD3 decreases ischemic injury derived apoptosis through phosphorylation of Erk1/2, Akt, and FoxO3a

Leukocyte trafficking is not affected by multikinase inhibitors sunitinib or sorafenib in mice

Ras Oncogene-Mediated Progressive Silencing of Extracellular Superoxide Dismutase in Tumorigenesis

Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation

Suchergebnisse filtern